By combining advanced technologies like real-time Ion Mass Spectrometry with user-friendly digital solutions, the project aims to improve diagnostic accuracy by 30% and help people receive the right treatment earlier. Clinical studies across Europe, involving over 3,600 participants, ensure these tools are tested and ready for real-world healthcare.
More than just technology, VOLABIOS focuses on ethical, practical solutions shaped by the voices of patients and communities. At its heart, the project is about changing the future of mental healthcare — starting with better ways to detect and understand schizophrenia.
